BioMarin Pharmaceutical (NASDAQ:BMRN)

buy sell stocks

Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More

Monday brought a much needed sell-off after two and half weeks of almost constant rallying, but the sell-off was minimal. Tuesday's opening indication on the S&P 500 and Dow is ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: GoPro, Randgold, Teva Pharma, Time Warner, Waste Management and More

Stocks were indicated handily higher, with the Dow up over 200 points and the S&P 500 up 29 points, after the FBI announced new information concerning the Clinton email review. ...
Read Full Story »
analysis

Top Analyst Upgrades and Downgrades: Brocade, Facebook, First Solar, Fitbit, ONEOK Partners, Sunrun and More

Stocks were indicated higher on Thursday after the Brexit theme has now switched to a softer Brexit path. This is also the first day of serious gains this week. Investors ...
Read Full Story »
biotech word cloud

Top Health Care Earnings Coming Next Week

Earnings season is now in full swing, and we have put together a preview of some of the world’s largest players in the health care sector. This current quarter ahead ...
Read Full Story »
bigger fish

3 Biotech Stocks Could Be the Next Big Takeover Targets

Just as the biotech segment was starting to regain lost ground, and was fast approaching 2016 highs, yet another speed bump was hit. The EpiPen controversy, and the resulting commentary again ...
Read Full Story »
money

Merrill Lynch Says the Time to Put Money Into Biotech Is Now

The Nasdaq Biotechnology Index has underperformed the broader market for some time. This year the index is still down about 13%, versus the 6% rise for the S&P 500. We ...
Read Full Story »
Test tubes

JPMorgan Bullish on Biotech: 3 Top Picks to Buy Now

We have noted recently that large pharmaceuticals and biotech have been hammered, and now may be offering outstanding total return potential. While the larger pharmaceutical stocks have done better recently, the ...
Read Full Story »
FDA_logo

4 Major FDA Decisions Expected by June

Pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a great amount ...
Read Full Story »
biotech word cloud

Analysts Make Major Changes to Top Biotech Ratings

At different times of the year, certain sectors come alive or slow down. Typically each year, the first quarter is the slowest for the biotechs, so many analysts tend to ...
Read Full Story »
Test tubes

4 Biotechs That Will Escape Weak Seasonal Trends for the Sector

All sectors of the market tend to have times of the year that are better than others, and biotechnology is no different. Typically each year, the first quarter is the ...
Read Full Story »
hospital entrance

Can BioMarin Make Treating Hemophilia More Affordable?

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is ready to break above the $1 billion revenue barrier in 2016. This is a feat that marks a major hurdle for many biotech and emerging ...
Read Full Story »
automatic inspection machine

Jefferies Identifies 5 Top Biotech Stocks for Huge Upside

Biotech stocks have been absolutely beaten up over the past eight months, even the iShares NASDAQ Biotechnology Index (NASDAQ: IBB) is down over 20% year to date. However this could ...
Read Full Story »
Female patient on gurney

BioMarin Sinks Despite Meeting Primary Endpoint

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) made waves early Monday following the release of late-stage results from its pegvaliase study. The company announced that the pivotal Phase 3 PRISM-2 study of pegvaliase ...
Read Full Story »
Starbucks coffee

4 Top Jefferies Growth Stocks to Buy With Big Upside Potential

After the massive rally on Friday, it will be interesting to see how the markets trade this week. Some anecdotal Wall Street data indicate that money managers and traders are still ...
Read Full Story »
FDA_logo

5 Key FDA Decisions Expected in March

Companies in the pharmaceutical industry are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, ...
Read Full Story »